Kevin Baker, MD
Diagnostic Radiology · Stony Brook, NYNPI 1053639484
Payments from drug & device makers
Across 320 payments — averaging $4967.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$389K
- EMD Serono, Inc.$284K
- Roche Products Limited$260K
- Astrazeneca UK Limited$174K
- Takeda Pharmaceuticals U.S.A., Inc.$172K
- AbbVie$109K
- plus $201K from 9 others
Across 88 payments — averaging $968.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$58K
- Boehringer Ingelheim International GmbH$27K
What the payments were for
- Consulting fees$446,630100%
- Food & beverage$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 95 | $388,710 |
| EMD Serono, Inc. | 36 | $284,180 |
| Roche Products Limited | 11 | $259,960 |
| Astrazeneca UK Limited | 9 | $174,295 |
| Takeda Pharmaceuticals U.S.A., Inc. | 62 | $172,040 |
| AbbVie | 33 | $109,475 |
| Hoffmann-la Roche Limited | 20 | $69,340 |
| Pfizer | 14 | $48,600 |
| F. Hoffmann-la Roche AG | 10 | $47,640 |
| Beigene (suzhou) Co., Ltd. | 9 | $14,840 |
| Beigene, Ltd. | 7 | $10,560 |
| Boehringer Ingelheim International GmbH | 6 | $7,710 |
| Astellas Pharma Inc | 6 | $1,140 |
| Boehringer Ingelheim | 1 | $1,050 |
| GE HealthCare | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,589,563 in reported general payments places this provider in the 95th percentile of 2,530 diagnostic radiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in Stony Brook
- Michael ReiterStony Brook$554K
- Steven WestStony Brook$269K
- Lev BangiyevStony Brook$148K
- Derace SchafferRochester$8.5M
- Constantinos SofocleousNew York$5.6M
- Lawrence SchwartzNew York$5.3M
- Thomas SosNew York$3.5M
- Hollis PotterNew York$3.1M
- Bachir TaouliNew York$1.7M
- Lawrence TanenbaumNew York$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.